92 related articles for article (PubMed ID: 1685656)
1. Ligand-independent tyrosine phosphorylation of the receptor encoded by the c-neu oncogene.
Boccaccio C; Gaudino G; Cilli M; Mondino A; Comoglio PM
Growth Factors; 1991; 5(3):233-42. PubMed ID: 1685656
[TBL] [Abstract][Full Text] [Related]
2. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
Kamps MP; Sefton BM
Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
[TBL] [Abstract][Full Text] [Related]
3. A 25 kDa polypeptide is the ligand for p185neu and is secreted by activated macrophages.
Tarakhovsky A; Zaichuk T; Prassolov V; Butenko ZA
Oncogene; 1991 Dec; 6(12):2187-96. PubMed ID: 1685016
[TBL] [Abstract][Full Text] [Related]
4. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine phosphatase inhibition permits analysis of signal transduction complexes in p185HER2/neu-overexpressing human tumor cells.
Jallal B; Schlessinger J; Ullrich A
J Biol Chem; 1992 Mar; 267(7):4357-63. PubMed ID: 1347042
[TBL] [Abstract][Full Text] [Related]
6. Downstream signal transduction defects that suppress transformation in two revertant cell lines expressing activated rat neu oncogene.
Reardon DB; Hung MC
J Biol Chem; 1993 Aug; 268(24):18136-42. PubMed ID: 7688739
[TBL] [Abstract][Full Text] [Related]
7. Experimental approaches to hypothetical hormones: detection of a candidate ligand of the neu protooncogene.
Yarden Y; Weinberg RA
Proc Natl Acad Sci U S A; 1989 May; 86(9):3179-83. PubMed ID: 2470093
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gamma.
Peles E; Levy RB; Or E; Ullrich A; Yarden Y
EMBO J; 1991 Aug; 10(8):2077-86. PubMed ID: 1676673
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of cellular platelet-derived growth factor receptors induced by an activated neu receptor tyrosine kinase.
Lehtola L; Nistér M; Hölttä E; Westermark B; Alitalo K
Cell Regul; 1991 Aug; 2(8):651-61. PubMed ID: 1685673
[TBL] [Abstract][Full Text] [Related]
10. Intracellular calcium regulates the tyrosine kinase receptor encoded by the MET oncogene.
Gandino L; Munaron L; Naldini L; Ferracini R; Magni M; Comoglio PM
J Biol Chem; 1991 Aug; 266(24):16098-104. PubMed ID: 1651934
[TBL] [Abstract][Full Text] [Related]
11. Cross-talk between phorbol ester-mediated signaling and tyrosine kinase proto-oncogenes. II. Comparison of phorbol ester and sphingomyelinase-induced phosphorylation of ErbB2 and ErbB3.
Emkey R; Kahn CR
J Biol Chem; 1997 Dec; 272(49):31182-9. PubMed ID: 9388272
[TBL] [Abstract][Full Text] [Related]
12. Regulated coupling of the Neu receptor to phosphatidylinositol 3'-kinase and its release by oncogenic activation.
Peles E; Lamprecht R; Ben-Levy R; Tzahar E; Yarden Y
J Biol Chem; 1992 Jun; 267(17):12266-74. PubMed ID: 1351056
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase-c activation inhibits tyrosine phosphorylation of the c-met protein.
Gandino L; Di Renzo MF; Giordano S; Bussolino F; Comoglio PM
Oncogene; 1990 May; 5(5):721-5. PubMed ID: 2111905
[TBL] [Abstract][Full Text] [Related]
14. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
Lanzi C; Borrello MG; Bongarzone I; Migliazza A; Fusco A; Grieco M; Santoro M; Gambetta RA; Zunino F; Della Porta G
Oncogene; 1992 Nov; 7(11):2189-94. PubMed ID: 1437145
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine kinase activity of the ret proto-oncogene products in vitro.
Miyazaki K; Asai N; Iwashita T; Taniguchi M; Isomura T; Funahashi H; Takagi H; Matsuyama M; Takahashi M
Biochem Biophys Res Commun; 1993 Jun; 193(2):565-70. PubMed ID: 7685595
[TBL] [Abstract][Full Text] [Related]
16. Biochemical comparisons of the normal and oncogenic forms of insect cell-expressed neu tyrosine kinases.
Guy PM; Carraway KL; Cerione RA
J Biol Chem; 1992 Jul; 267(20):13851-6. PubMed ID: 1352772
[TBL] [Abstract][Full Text] [Related]
17. Carboxyl-terminal deletion and point mutations decrease the transforming potential of the activated rat neu oncogene product.
Mikami Y; Davis JG; Dobashi K; Dougall WC; Myers JN; Brown VI; Greene MI
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7335-9. PubMed ID: 1354355
[TBL] [Abstract][Full Text] [Related]
18. Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene.
Bargmann CI; Weinberg RA
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5394-8. PubMed ID: 2899890
[TBL] [Abstract][Full Text] [Related]
19. Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro.
Meisenhelder J; Suh PG; Rhee SG; Hunter T
Cell; 1989 Jun; 57(7):1109-22. PubMed ID: 2472219
[TBL] [Abstract][Full Text] [Related]
20. Ligand-independent tyrosine phosphorylation of EGF receptor and the erbB-2/neu proto-oncogene product is induced by hyperosmotic shock.
King CR; Borrello I; Porter L; Comoglio P; Schlessinger J
Oncogene; 1989 Jan; 4(1):13-8. PubMed ID: 2464783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]